Table 1

The gene expression datasets used in this study
Name Cancer type #Gene Platform #Patients Pathological settings
Lin07 colorectal cancer 4428 Affymetrix Human Genome U133A Array 55 29 non-recurrence vs. 26 recurrence
Barrier06 colorectal cancer 4428 Affymetrix Human Genome U133A Array 50 25 non-recurrence vs. 25 recurrence
Wang05 breast cancer 4428 Affymetrix Human Genome U133A Array 286 180 non-metastasis vs. 106 metastasis
Van02 breast cancer 4203 Agilent oligonucleotide Hu25K microarray 295 217 non-metastasis vs. 78 metastasis
Jones05 clear-cell renal cell carcinoma 4428 Affymetrix Human Genome U133A Array 55 23 normal vs. 32 ccRCC
Wuttig09 clear-cell renal cell carcinoma 4428 Affymetrix Human Genome U133 Plus 2.0 Array 68 29 good prognosis vs. 39 poor prognosis
Sanchez10 non-small cell lung cancer 4428 Affymetrix Human Genome U133 Plus 2.0 Array 91 45 normal vs. 46 tumor
Beer02 non-small cell lung cancer 2644 Affymetrix Human Full Length HuGeneFL Array 86 24 dead vs. 62 alive
Riker08 melanoma 4428 Affymetrix Human Genome U133 Plus 2.0 Array 82 42 non-metastatic vs. 40 metastatic
Freije04 gliomas 4428 Affymetrix Human Genome U133A Array 85 59 dead vs. 26 alive

Li et al.

Li et al. BMC Systems Biology 2012 6:64   doi:10.1186/1752-0509-6-64

Open Data